nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—ALB—melanoma	0.442	1	CbGaD
Auranofin—ALB—Vemurafenib—melanoma	0.152	1	CbGbCtD
Auranofin—PRDX5—neck—melanoma	0.00641	0.202	CbGeAlD
Auranofin—PRDX5—eye—melanoma	0.00477	0.15	CbGeAlD
Auranofin—PRDX5—skin of body—melanoma	0.00415	0.13	CbGeAlD
Auranofin—PRDX5—mammalian vulva—melanoma	0.00379	0.119	CbGeAlD
Auranofin—Interstitial pneumonia—Temozolomide—melanoma	0.00329	0.0321	CcSEcCtD
Auranofin—PRDX5—head—melanoma	0.00271	0.0851	CbGeAlD
Auranofin—Interstitial lung disease—Bleomycin—melanoma	0.00266	0.026	CcSEcCtD
Auranofin—IKBKB—skin of body—melanoma	0.00246	0.0773	CbGeAlD
Auranofin—Interstitial lung disease—Carmustine—melanoma	0.00232	0.0227	CcSEcCtD
Auranofin—Interstitial lung disease—Temozolomide—melanoma	0.00225	0.0219	CcSEcCtD
Auranofin—IKBKB—mammalian vulva—melanoma	0.00224	0.0705	CbGeAlD
Auranofin—Interstitial pneumonia—Docetaxel—melanoma	0.00219	0.0214	CcSEcCtD
Auranofin—Eosinophilia—Vemurafenib—melanoma	0.00193	0.0189	CcSEcCtD
Auranofin—PRDX5—lymph node—melanoma	0.0019	0.0596	CbGeAlD
Auranofin—Weight decreased—Vemurafenib—melanoma	0.00177	0.0172	CcSEcCtD
Auranofin—Neuropathy peripheral—Vemurafenib—melanoma	0.00171	0.0166	CcSEcCtD
Auranofin—Hepatic enzyme increased—Temozolomide—melanoma	0.00168	0.0164	CcSEcCtD
Auranofin—Aplastic anaemia—Dactinomycin—melanoma	0.00165	0.0161	CcSEcCtD
Auranofin—IKBKB—head—melanoma	0.0016	0.0504	CbGeAlD
Auranofin—Interstitial lung disease—Docetaxel—melanoma	0.00149	0.0146	CcSEcCtD
Auranofin—Aplastic anaemia—Temozolomide—melanoma	0.00149	0.0146	CcSEcCtD
Auranofin—Eye disorder—Vemurafenib—melanoma	0.00146	0.0142	CcSEcCtD
Auranofin—Alopecia—Vemurafenib—melanoma	0.00138	0.0135	CcSEcCtD
Auranofin—Dysgeusia—Vemurafenib—melanoma	0.00133	0.013	CcSEcCtD
Auranofin—Dermatitis exfoliative—Temozolomide—melanoma	0.00122	0.0119	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Carmustine—melanoma	0.00119	0.0117	CcSEcCtD
Auranofin—Pancytopenia—Bleomycin—melanoma	0.00112	0.011	CcSEcCtD
Auranofin—IKBKB—lymph node—melanoma	0.00112	0.0353	CbGeAlD
Auranofin—Dysphagia—Dactinomycin—melanoma	0.0011	0.0108	CcSEcCtD
Auranofin—Weight decreased—Bleomycin—melanoma	0.00107	0.0104	CcSEcCtD
Auranofin—Pancytopenia—Dactinomycin—melanoma	0.00105	0.0102	CcSEcCtD
Auranofin—Dysphagia—Carmustine—melanoma	0.00103	0.0101	CcSEcCtD
Auranofin—Neutropenia—Dactinomycin—melanoma	0.00103	0.0101	CcSEcCtD
Auranofin—Stomatitis—Bleomycin—melanoma	0.00103	0.01	CcSEcCtD
Auranofin—Haematuria—Bleomycin—melanoma	0.00101	0.00981	CcSEcCtD
Auranofin—Dysphagia—Temozolomide—melanoma	0.000998	0.00973	CcSEcCtD
Auranofin—Pancytopenia—Carmustine—melanoma	0.00098	0.00957	CcSEcCtD
Auranofin—Neutropenia—Carmustine—melanoma	0.000965	0.00942	CcSEcCtD
Auranofin—Decreased appetite—Vemurafenib—melanoma	0.000965	0.00942	CcSEcCtD
Auranofin—Stomatitis—Dactinomycin—melanoma	0.000959	0.00935	CcSEcCtD
Auranofin—Constipation—Vemurafenib—melanoma	0.000949	0.00926	CcSEcCtD
Auranofin—Pancytopenia—Temozolomide—melanoma	0.000947	0.00924	CcSEcCtD
Auranofin—Neutropenia—Temozolomide—melanoma	0.000933	0.0091	CcSEcCtD
Auranofin—Agranulocytosis—Dactinomycin—melanoma	0.000918	0.00896	CcSEcCtD
Auranofin—Weight decreased—Temozolomide—melanoma	0.000903	0.00881	CcSEcCtD
Auranofin—Neuropathy peripheral—Carmustine—melanoma	0.000902	0.0088	CcSEcCtD
Auranofin—Stomatitis—Carmustine—melanoma	0.000897	0.00875	CcSEcCtD
Auranofin—Neuropathy peripheral—Temozolomide—melanoma	0.000872	0.00851	CcSEcCtD
Auranofin—Stomatitis—Temozolomide—melanoma	0.000867	0.00846	CcSEcCtD
Auranofin—Alopecia—Bleomycin—melanoma	0.000837	0.00816	CcSEcCtD
Auranofin—Visual impairment—Carmustine—melanoma	0.000796	0.00777	CcSEcCtD
Auranofin—Pruritus—Vemurafenib—melanoma	0.000785	0.00766	CcSEcCtD
Auranofin—Alopecia—Dactinomycin—melanoma	0.00078	0.00761	CcSEcCtD
Auranofin—Eye disorder—Carmustine—melanoma	0.000772	0.00754	CcSEcCtD
Auranofin—Visual impairment—Temozolomide—melanoma	0.00077	0.00751	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000768	0.00749	CcSEcCtD
Auranofin—Anaemia—Bleomycin—melanoma	0.000762	0.00743	CcSEcCtD
Auranofin—Diarrhoea—Vemurafenib—melanoma	0.00076	0.00741	CcSEcCtD
Auranofin—Eye disorder—Temozolomide—melanoma	0.000746	0.00728	CcSEcCtD
Auranofin—Leukopenia—Bleomycin—melanoma	0.000738	0.0072	CcSEcCtD
Auranofin—Alopecia—Carmustine—melanoma	0.00073	0.00712	CcSEcCtD
Auranofin—Anaemia—Dactinomycin—melanoma	0.00071	0.00693	CcSEcCtD
Auranofin—Vomiting—Vemurafenib—melanoma	0.000706	0.00689	CcSEcCtD
Auranofin—Alopecia—Temozolomide—melanoma	0.000706	0.00689	CcSEcCtD
Auranofin—Rash—Vemurafenib—melanoma	0.0007	0.00683	CcSEcCtD
Auranofin—Dermatitis—Vemurafenib—melanoma	0.000699	0.00682	CcSEcCtD
Auranofin—Leukopenia—Dactinomycin—melanoma	0.000688	0.00671	CcSEcCtD
Auranofin—Dysgeusia—Temozolomide—melanoma	0.000681	0.00664	CcSEcCtD
Auranofin—Anaemia—Carmustine—melanoma	0.000665	0.00649	CcSEcCtD
Auranofin—Dysphagia—Docetaxel—melanoma	0.000663	0.00647	CcSEcCtD
Auranofin—Nausea—Vemurafenib—melanoma	0.000659	0.00643	CcSEcCtD
Auranofin—Thrombocytopenia—Bleomycin—melanoma	0.000659	0.00643	CcSEcCtD
Auranofin—ALB—lymph node—melanoma	0.000655	0.0206	CbGeAlD
Auranofin—Leukopenia—Carmustine—melanoma	0.000644	0.00628	CcSEcCtD
Auranofin—Anaemia—Temozolomide—melanoma	0.000642	0.00627	CcSEcCtD
Auranofin—Anorexia—Bleomycin—melanoma	0.000641	0.00626	CcSEcCtD
Auranofin—Angioedema—Temozolomide—melanoma	0.000635	0.0062	CcSEcCtD
Auranofin—Pancytopenia—Docetaxel—melanoma	0.00063	0.00615	CcSEcCtD
Auranofin—Leukopenia—Temozolomide—melanoma	0.000622	0.00607	CcSEcCtD
Auranofin—Neutropenia—Docetaxel—melanoma	0.00062	0.00605	CcSEcCtD
Auranofin—Thrombocytopenia—Dactinomycin—melanoma	0.000614	0.00599	CcSEcCtD
Auranofin—Weight decreased—Docetaxel—melanoma	0.0006	0.00586	CcSEcCtD
Auranofin—Anorexia—Dactinomycin—melanoma	0.000598	0.00583	CcSEcCtD
Auranofin—Decreased appetite—Bleomycin—melanoma	0.000585	0.0057	CcSEcCtD
Auranofin—Neuropathy peripheral—Docetaxel—melanoma	0.00058	0.00566	CcSEcCtD
Auranofin—Stomatitis—Docetaxel—melanoma	0.000577	0.00563	CcSEcCtD
Auranofin—Jaundice—Docetaxel—melanoma	0.000577	0.00563	CcSEcCtD
Auranofin—Conjunctivitis—Docetaxel—melanoma	0.000575	0.00561	CcSEcCtD
Auranofin—Thrombocytopenia—Carmustine—melanoma	0.000575	0.00561	CcSEcCtD
Auranofin—Anorexia—Carmustine—melanoma	0.00056	0.00546	CcSEcCtD
Auranofin—Thrombocytopenia—Temozolomide—melanoma	0.000555	0.00542	CcSEcCtD
Auranofin—Agranulocytosis—Docetaxel—melanoma	0.000552	0.00539	CcSEcCtD
Auranofin—Decreased appetite—Dactinomycin—melanoma	0.000545	0.00532	CcSEcCtD
Auranofin—Anorexia—Temozolomide—melanoma	0.000541	0.00528	CcSEcCtD
Auranofin—Urticaria—Bleomycin—melanoma	0.000534	0.00521	CcSEcCtD
Auranofin—Gastrointestinal pain—Dactinomycin—melanoma	0.000513	0.005	CcSEcCtD
Auranofin—Visual impairment—Docetaxel—melanoma	0.000512	0.00499	CcSEcCtD
Auranofin—Decreased appetite—Carmustine—melanoma	0.00051	0.00498	CcSEcCtD
Auranofin—Constipation—Carmustine—melanoma	0.000502	0.0049	CcSEcCtD
Auranofin—Dyspepsia—Temozolomide—melanoma	0.000499	0.00487	CcSEcCtD
Auranofin—Eye disorder—Docetaxel—melanoma	0.000496	0.00484	CcSEcCtD
Auranofin—Abdominal pain—Dactinomycin—melanoma	0.000496	0.00484	CcSEcCtD
Auranofin—Decreased appetite—Temozolomide—melanoma	0.000493	0.00481	CcSEcCtD
Auranofin—Constipation—Temozolomide—melanoma	0.000485	0.00473	CcSEcCtD
Auranofin—Gastrointestinal pain—Carmustine—melanoma	0.00048	0.00468	CcSEcCtD
Auranofin—Pruritus—Bleomycin—melanoma	0.000476	0.00464	CcSEcCtD
Auranofin—Alopecia—Docetaxel—melanoma	0.000469	0.00458	CcSEcCtD
Auranofin—Abdominal pain—Carmustine—melanoma	0.000464	0.00453	CcSEcCtD
Auranofin—Gastrointestinal pain—Temozolomide—melanoma	0.000464	0.00453	CcSEcCtD
Auranofin—Dysgeusia—Docetaxel—melanoma	0.000453	0.00442	CcSEcCtD
Auranofin—Urticaria—Temozolomide—melanoma	0.000451	0.0044	CcSEcCtD
Auranofin—Abdominal pain—Temozolomide—melanoma	0.000448	0.00438	CcSEcCtD
Auranofin—Diarrhoea—Dactinomycin—melanoma	0.000429	0.00419	CcSEcCtD
Auranofin—Vomiting—Bleomycin—melanoma	0.000428	0.00417	CcSEcCtD
Auranofin—Anaemia—Docetaxel—melanoma	0.000427	0.00417	CcSEcCtD
Auranofin—Rash—Bleomycin—melanoma	0.000424	0.00414	CcSEcCtD
Auranofin—Dermatitis—Bleomycin—melanoma	0.000424	0.00413	CcSEcCtD
Auranofin—Leukopenia—Docetaxel—melanoma	0.000414	0.00404	CcSEcCtD
Auranofin—Diarrhoea—Carmustine—melanoma	0.000402	0.00392	CcSEcCtD
Auranofin—Pruritus—Temozolomide—melanoma	0.000401	0.00392	CcSEcCtD
Auranofin—Nausea—Bleomycin—melanoma	0.000399	0.0039	CcSEcCtD
Auranofin—Vomiting—Dactinomycin—melanoma	0.000399	0.00389	CcSEcCtD
Auranofin—Rash—Dactinomycin—melanoma	0.000395	0.00386	CcSEcCtD
Auranofin—Diarrhoea—Temozolomide—melanoma	0.000388	0.00379	CcSEcCtD
Auranofin—Vomiting—Carmustine—melanoma	0.000373	0.00364	CcSEcCtD
Auranofin—Nausea—Dactinomycin—melanoma	0.000373	0.00364	CcSEcCtD
Auranofin—Rash—Carmustine—melanoma	0.00037	0.00361	CcSEcCtD
Auranofin—Dermatitis—Carmustine—melanoma	0.00037	0.00361	CcSEcCtD
Auranofin—Thrombocytopenia—Docetaxel—melanoma	0.000369	0.0036	CcSEcCtD
Auranofin—Vomiting—Temozolomide—melanoma	0.000361	0.00352	CcSEcCtD
Auranofin—Anorexia—Docetaxel—melanoma	0.00036	0.00351	CcSEcCtD
Auranofin—Rash—Temozolomide—melanoma	0.000358	0.00349	CcSEcCtD
Auranofin—Dermatitis—Temozolomide—melanoma	0.000357	0.00349	CcSEcCtD
Auranofin—Nausea—Carmustine—melanoma	0.000349	0.0034	CcSEcCtD
Auranofin—Nausea—Temozolomide—melanoma	0.000337	0.00329	CcSEcCtD
Auranofin—Dyspepsia—Docetaxel—melanoma	0.000332	0.00324	CcSEcCtD
Auranofin—Decreased appetite—Docetaxel—melanoma	0.000328	0.0032	CcSEcCtD
Auranofin—Constipation—Docetaxel—melanoma	0.000323	0.00315	CcSEcCtD
Auranofin—Gastrointestinal pain—Docetaxel—melanoma	0.000309	0.00301	CcSEcCtD
Auranofin—Abdominal pain—Docetaxel—melanoma	0.000298	0.00291	CcSEcCtD
Auranofin—Pruritus—Docetaxel—melanoma	0.000267	0.0026	CcSEcCtD
Auranofin—Diarrhoea—Docetaxel—melanoma	0.000258	0.00252	CcSEcCtD
Auranofin—Vomiting—Docetaxel—melanoma	0.00024	0.00234	CcSEcCtD
Auranofin—Rash—Docetaxel—melanoma	0.000238	0.00232	CcSEcCtD
Auranofin—Dermatitis—Docetaxel—melanoma	0.000238	0.00232	CcSEcCtD
Auranofin—Nausea—Docetaxel—melanoma	0.000224	0.00219	CcSEcCtD
Auranofin—ALB—Metabolism—PIP4K2A—melanoma	3.74e-05	0.000138	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ITGAV—melanoma	3.73e-05	0.000137	CbGpPWpGaD
Auranofin—IKBKB—Immune System—AKT3—melanoma	3.73e-05	0.000137	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—MAPK1—melanoma	3.73e-05	0.000137	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—EGFR—melanoma	3.73e-05	0.000137	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CASP8—melanoma	3.68e-05	0.000135	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IFNA2—melanoma	3.68e-05	0.000135	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SLC5A5—melanoma	3.66e-05	0.000134	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IFNA2—melanoma	3.65e-05	0.000134	CbGpPWpGaD
Auranofin—ALB—Metabolism—MTAP—melanoma	3.64e-05	0.000134	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCR2—melanoma	3.62e-05	0.000133	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—AKT1—melanoma	3.59e-05	0.000132	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—KRAS—melanoma	3.59e-05	0.000132	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RAC2—melanoma	3.56e-05	0.000131	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	3.56e-05	0.000131	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—KRAS—melanoma	3.52e-05	0.00013	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—WNT5A—melanoma	3.5e-05	0.000129	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—VEGFC—melanoma	3.5e-05	0.000129	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MAP2K1—melanoma	3.5e-05	0.000129	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CDH1—melanoma	3.49e-05	0.000128	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PIK3CD—melanoma	3.48e-05	0.000128	CbGpPWpGaD
Auranofin—IKBKB—Immune System—SOCS1—melanoma	3.46e-05	0.000127	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PIK3CB—melanoma	3.45e-05	0.000127	CbGpPWpGaD
Auranofin—IKBKB—Immune System—S100B—melanoma	3.45e-05	0.000127	CbGpPWpGaD
Auranofin—ALB—Hemostasis—ITGB1—melanoma	3.42e-05	0.000126	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ITGB1—melanoma	3.39e-05	0.000125	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PIK3CD—melanoma	3.34e-05	0.000123	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—FGF2—melanoma	3.33e-05	0.000122	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ERBB4—melanoma	3.3e-05	0.000121	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—PIK3CA—melanoma	3.29e-05	0.000121	CbGpPWpGaD
Auranofin—ALB—Metabolism—PHGDH—melanoma	3.25e-05	0.000119	CbGpPWpGaD
Auranofin—ALB—Metabolism—LUM—melanoma	3.25e-05	0.000119	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—PIK3CA—melanoma	3.24e-05	0.000119	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—FGF2—melanoma	3.2e-05	0.000118	CbGpPWpGaD
Auranofin—ALB—Metabolism—HPSE—melanoma	3.18e-05	0.000117	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—IL2—melanoma	3.17e-05	0.000117	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD86—melanoma	3.16e-05	0.000116	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—BCL2—melanoma	3.16e-05	0.000116	CbGpPWpGaD
Auranofin—ALB—Hemostasis—HGF—melanoma	3.13e-05	0.000115	CbGpPWpGaD
Auranofin—ALB—Metabolism—CUBN—melanoma	3.13e-05	0.000115	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MDM2—melanoma	3.11e-05	0.000115	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HGF—melanoma	3.1e-05	0.000114	CbGpPWpGaD
Auranofin—ALB—Hemostasis—CSF2—melanoma	3.09e-05	0.000114	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—F2R—melanoma	3.08e-05	0.000113	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—ERBB2—melanoma	3.07e-05	0.000113	CbGpPWpGaD
Auranofin—IKBKB—Immune System—FGF1—melanoma	3.07e-05	0.000113	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD8A—melanoma	3.07e-05	0.000113	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CSF2—melanoma	3.07e-05	0.000113	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—HRAS—melanoma	3.05e-05	0.000112	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PIK3CB—melanoma	3.03e-05	0.000111	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CD4—melanoma	3.02e-05	0.000111	CbGpPWpGaD
Auranofin—ALB—Metabolism—SDHD—melanoma	3.02e-05	0.000111	CbGpPWpGaD
Auranofin—ALB—Metabolism—BSG—melanoma	3.02e-05	0.000111	CbGpPWpGaD
Auranofin—ALB—Metabolism—CSPG4—melanoma	3.02e-05	0.000111	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—HRAS—melanoma	3e-05	0.00011	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—MDM2—melanoma	2.99e-05	0.00011	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EDNRB—melanoma	2.98e-05	0.00011	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PDGFRA—melanoma	2.97e-05	0.000109	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PRKCA—melanoma	2.96e-05	0.000109	CbGpPWpGaD
Auranofin—ALB—Hemostasis—ITGB3—melanoma	2.96e-05	0.000109	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HLA-B—melanoma	2.95e-05	0.000108	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—ERBB2—melanoma	2.95e-05	0.000108	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PRKCA—melanoma	2.94e-05	0.000108	CbGpPWpGaD
Auranofin—ALB—Metabolism—GPAM—melanoma	2.92e-05	0.000107	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL6—melanoma	2.92e-05	0.000107	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PIK3CB—melanoma	2.91e-05	0.000107	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD4—melanoma	2.9e-05	0.000107	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTK2B—melanoma	2.89e-05	0.000106	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MAP2K2—melanoma	2.87e-05	0.000106	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—IL6—melanoma	2.87e-05	0.000105	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CDKN1B—melanoma	2.84e-05	0.000105	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GAB2—melanoma	2.81e-05	0.000103	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GNA11—melanoma	2.81e-05	0.000103	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FLT1—melanoma	2.8e-05	0.000103	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—ABCB1—melanoma	2.79e-05	0.000103	CbGpPWpGaD
Auranofin—ALB—Hemostasis—RAC1—melanoma	2.75e-05	0.000101	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HLA-A—melanoma	2.73e-05	0.000101	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CDKN1B—melanoma	2.73e-05	0.0001	CbGpPWpGaD
Auranofin—IKBKB—Immune System—RAC1—melanoma	2.73e-05	0.0001	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—VEGFA—melanoma	2.69e-05	9.9e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CTNNB1—melanoma	2.69e-05	9.88e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—MMP1—melanoma	2.66e-05	9.77e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCR4—melanoma	2.65e-05	9.73e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HDAC2—melanoma	2.65e-05	9.73e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FOXO4—melanoma	2.65e-05	9.73e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—AKT1—melanoma	2.65e-05	9.73e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CDKN1A—melanoma	2.62e-05	9.65e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PTEN—melanoma	2.62e-05	9.63e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GNAQ—melanoma	2.62e-05	9.62e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—CDK2—melanoma	2.61e-05	9.59e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—NFKB1—melanoma	2.61e-05	9.58e-05	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—MAPK3—melanoma	2.55e-05	9.37e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CDKN1A—melanoma	2.52e-05	9.27e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PTEN—melanoma	2.51e-05	9.24e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—NFKB1—melanoma	2.5e-05	9.2e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—TLR4—melanoma	2.5e-05	9.19e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HLA-DRB1—melanoma	2.5e-05	9.18e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PLA2G6—melanoma	2.49e-05	9.14e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SYK—melanoma	2.46e-05	9.05e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—FN1—melanoma	2.43e-05	8.92e-05	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—MAPK1—melanoma	2.42e-05	8.91e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ITGAV—melanoma	2.41e-05	8.88e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AKT3—melanoma	2.41e-05	8.88e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NGFR—melanoma	2.41e-05	8.88e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ICAM1—melanoma	2.4e-05	8.81e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—NOS2—melanoma	2.4e-05	8.81e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—NRAS—melanoma	2.34e-05	8.59e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CG—melanoma	2.32e-05	8.54e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD80—melanoma	2.31e-05	8.48e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—KIT—melanoma	2.3e-05	8.47e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—EGF—melanoma	2.29e-05	8.44e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—EGF—melanoma	2.28e-05	8.37e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—NRAS—melanoma	2.24e-05	8.25e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MAPK3—melanoma	2.24e-05	8.23e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SOCS1—melanoma	2.24e-05	8.22e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—VCAN—melanoma	2.23e-05	8.21e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—S100B—melanoma	2.23e-05	8.2e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CASP8—melanoma	2.14e-05	7.89e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ERBB4—melanoma	2.13e-05	7.84e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MAPK1—melanoma	2.13e-05	7.83e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—EGFR—melanoma	2.13e-05	7.83e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IGF1—melanoma	2.13e-05	7.82e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CDH1—melanoma	2.12e-05	7.79e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CDKN2B—melanoma	2.11e-05	7.77e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.11e-05	7.77e-05	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PIK3CA—melanoma	2.1e-05	7.74e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CD86—melanoma	2.04e-05	7.52e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—EGFR—melanoma	2.04e-05	7.51e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CD—melanoma	2.04e-05	7.5e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.04e-05	7.5e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MAP2K1—melanoma	2.04e-05	7.49e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EDN1—melanoma	2.03e-05	7.46e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PIK3CD—melanoma	2.02e-05	7.44e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—KRAS—melanoma	2.01e-05	7.39e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CSF2—melanoma	1.98e-05	7.29e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FGF1—melanoma	1.98e-05	7.29e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—E2F1—melanoma	1.94e-05	7.14e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—FGF2—melanoma	1.94e-05	7.13e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—KRAS—melanoma	1.93e-05	7.1e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PDGFRA—melanoma	1.92e-05	7.06e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ITGB3—melanoma	1.9e-05	6.99e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PRKCA—melanoma	1.9e-05	6.99e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP17A1—melanoma	1.88e-05	6.93e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SPP1—melanoma	1.86e-05	6.86e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MAP2K2—melanoma	1.86e-05	6.83e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.86e-05	6.83e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PIK3CA—melanoma	1.85e-05	6.79e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—BCL2—melanoma	1.84e-05	6.77e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IFNG—melanoma	1.82e-05	6.71e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MDM2—melanoma	1.81e-05	6.67e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ERBB2—melanoma	1.79e-05	6.58e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—GNA11—melanoma	1.78e-05	6.54e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CB—melanoma	1.78e-05	6.54e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PIK3CA—melanoma	1.77e-05	6.52e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TERT—melanoma	1.77e-05	6.5e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PIK3CB—melanoma	1.76e-05	6.49e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RAC1—melanoma	1.76e-05	6.48e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD4—melanoma	1.76e-05	6.48e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—FASN—melanoma	1.74e-05	6.4e-05	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	1.72e-05	6.32e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—SLC5A5—melanoma	1.71e-05	6.3e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—HRAS—melanoma	1.71e-05	6.28e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HIF1A—melanoma	1.69e-05	6.21e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CDKN1B—melanoma	1.66e-05	6.09e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CD44—melanoma	1.65e-05	6.08e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—GNAQ—melanoma	1.65e-05	6.08e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HRAS—melanoma	1.64e-05	6.03e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IL6—melanoma	1.64e-05	6.01e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IL2—melanoma	1.63e-05	6.01e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL2—melanoma	1.62e-05	5.96e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.62e-05	5.95e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KDR—melanoma	1.62e-05	5.94e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.6e-05	5.9e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP1B1—melanoma	1.59e-05	5.83e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CTNNB1—melanoma	1.56e-05	5.75e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FN1—melanoma	1.56e-05	5.72e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CDKN1A—melanoma	1.53e-05	5.62e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PTEN—melanoma	1.52e-05	5.61e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NOTCH1—melanoma	1.52e-05	5.6e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—NFKB1—melanoma	1.52e-05	5.58e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—AKT1—melanoma	1.51e-05	5.55e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CD80—melanoma	1.49e-05	5.49e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CG—melanoma	1.49e-05	5.48e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KIT—melanoma	1.49e-05	5.48e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APC—melanoma	1.49e-05	5.48e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EGF—melanoma	1.47e-05	5.41e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—AKT1—melanoma	1.45e-05	5.33e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—BRAF—melanoma	1.4e-05	5.15e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.4e-05	5.15e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—VEGFA—melanoma	1.39e-05	5.1e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—NRAS—melanoma	1.37e-05	5.04e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—STAT3—melanoma	1.36e-05	5.01e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IGF1—melanoma	1.36e-05	5.01e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—NRAS—melanoma	1.36e-05	5e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MAP2K1—melanoma	1.32e-05	4.85e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—MAPK3—melanoma	1.31e-05	4.83e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CD—melanoma	1.31e-05	4.81e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—ABCB1—melanoma	1.31e-05	4.8e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MAPK3—melanoma	1.3e-05	4.79e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FGF2—melanoma	1.25e-05	4.61e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—MAPK1—melanoma	1.25e-05	4.59e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MAPK1—melanoma	1.24e-05	4.56e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—EGFR—melanoma	1.24e-05	4.56e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PRKCA—melanoma	1.2e-05	4.42e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—ERCC2—melanoma	1.19e-05	4.38e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—KRAS—melanoma	1.18e-05	4.34e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MDM2—melanoma	1.17e-05	4.31e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—KRAS—melanoma	1.17e-05	4.31e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ERBB2—melanoma	1.16e-05	4.25e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CB—melanoma	1.14e-05	4.2e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCL8—melanoma	1.1e-05	4.03e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CA—melanoma	1.08e-05	3.99e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PIK3CA—melanoma	1.08e-05	3.96e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CDKN1B—melanoma	1.07e-05	3.94e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CASP3—melanoma	1.05e-05	3.86e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TP53—melanoma	1.05e-05	3.86e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL2—melanoma	1.05e-05	3.85e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCND1—melanoma	1.02e-05	3.76e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CTNNB1—melanoma	1.01e-05	3.72e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—HRAS—melanoma	1e-05	3.69e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HRAS—melanoma	9.95e-06	3.66e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MMP9—melanoma	9.92e-06	3.65e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CDKN1A—melanoma	9.88e-06	3.63e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	9.87e-06	3.63e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTEN—melanoma	9.86e-06	3.63e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NFKB1—melanoma	9.81e-06	3.61e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL6—melanoma	9.53e-06	3.5e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CG—melanoma	9.41e-06	3.46e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PPARG—melanoma	9.08e-06	3.34e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—VEGFA—melanoma	8.91e-06	3.27e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—AKT1—melanoma	8.86e-06	3.26e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—STAT3—melanoma	8.82e-06	3.24e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NRAS—melanoma	8.8e-06	3.23e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—AKT1—melanoma	8.79e-06	3.23e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MAPK3—melanoma	8.42e-06	3.1e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CD—melanoma	8.27e-06	3.04e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MYC—melanoma	8.19e-06	3.01e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MAPK1—melanoma	8.02e-06	2.95e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EGFR—melanoma	8.01e-06	2.95e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KRAS—melanoma	7.57e-06	2.78e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CB—melanoma	7.21e-06	2.65e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PTGS2—melanoma	7.15e-06	2.63e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CA—melanoma	6.96e-06	2.56e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TP53—melanoma	6.73e-06	2.47e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HRAS—melanoma	6.44e-06	2.37e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PTEN—melanoma	6.23e-06	2.29e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL6—melanoma	6.16e-06	2.26e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AKT1—melanoma	5.68e-06	2.09e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CA—melanoma	4.4e-06	1.62e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—AKT1—melanoma	3.59e-06	1.32e-05	CbGpPWpGaD
